A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

RECRUITING

Westmead Hospital /ID# 255200, Westmead

RECRUITING

Box Hill Hospital /ID# 255199, Box Hill

RECRUITING

Princess Alexandra Hospital /ID# 255202, Woolloongabba

RECRUITING

Alexandra General Hospital /ID# 255542, Athens

RECRUITING

Levine Cancer Institute /ID# 255074, Charlotte

RECRUITING

CHU Toulouse - Hopital Rangueil /ID# 255377, Toulouse

RECRUITING

Sylvester Comprehensive Cancer Center - University of Miami /ID# 255856, Miami

RECRUITING

IRCCS AOU di Bologna Policlinico Sant Orsola Malpighi /ID# 255654, Bologna

RECRUITING

Wisconsin Medical Center /ID# 255836, Milwaukee

RECRUITING

CHU Limoges - Dupuytren 1 /ID# 255370, Limoges

RECRUITING

Oregon Medical Research Center /ID# 255119, Portland

RECRUITING

University of Washington /ID# 261581, Seattle

RECRUITING

Kumamoto University Hospital /ID# 262579, Kumamoto

RECRUITING

Boston Medical Center /ID# 255066, Boston

RECRUITING

Mayo Clinic - Rochester /ID# 255258, Rochester

RECRUITING

Columbia University Medical Center /ID# 255068, New York

RECRUITING

Memorial Sloan Kettering Cancer Center-Koch Center /ID# 255073, New York

RECRUITING

Wake Forest Baptist Health /ID# 255851, Winston-Salem

RECRUITING

Nagoya City University Hospital /ID# 256086, Nagoya

RECRUITING

Japanese Red Cross Medical Center /ID# 256083, Shibuya-ku